| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Jun―04 |
Use of supervised machine learning algorithms to detect pre-existing neurocognitive disorders in hospitalized adults with COVID-19: a classification study |
Juan M. Marquez-Romero, Svetlana V. Doubova, Flavio Cuellar-Roque, Carlos A. Prado-Aguilar, Alicia Alanis-Ocadiz, Jannett Padilla-López, et al. (+4) Diana C. Navarro-Rodríguez, Carolina Quiñones-Villalobos, Ángel E. Muñoz-Zavala, Rogelio Salinas-Gutiérrez |
| 2 |
[GO] |
2025―Sep―29 |
Optic neuritis associated COVID-19 vaccine: a systematic review for clinical characteristics of an uncommon side effect |
Marlon R. Dionisio, Juan C. Martínez-Lazcano, Graciela Cárdenas |
| 3 |
[GO] |
2024―Jun―05 |
Effects of the COVID-19 pandemic on mental health and cognition after isolation and reassessment of remote care. A review article |
Brenda V. Rabago-Barajas, Adriana Aguayo-Arelis, Joaquin García-Estrada, Jesús E. Arana-Yepez |
| 4 |
[GO] |
2024―May―13 |
SARS-CoV-2 effect on cognitive function and subjective perception of executive functions in individuals in prison in Colombia |
Diana P. Caicedo-Navarro |
| 5 |
[GO] |
2023―May―16 |
The psychoneuroendocrine response of aggression due to COVID-19 social isolation |
Angelica M. Palacio-Delgado, Miguel B. Cervera-Sánchez, Anna C. Selvas-Cortinas, Samuel A. Romo-Márquez, Judith M. Dueñas-Jiménez |
| 6 |
[GO] |
2023―Jan―16 |
COVID-19 and diabetes mellitus in cognitive impairment: an undrawn relationship |
Antonio Anaya-Escamilla, Luis E. Martínez-Bravo, Gilberto A. Jiménez-Castillo |
| 7 |
[GO] |
2022―Jul―08 |
Cognitive impairment in people with COVID-19 with mild-moderate symptoms in Ecuador |
Alejandro Checa, Eliana Navas, Verónica Valencia, Jessica Alcívar |
| 8 |
[GO] |
2021―Jul―06 |
Obstructive sleep apnea (OSA) should be considered a comorbidity as a risk factor for COVID-19 fatality: A review. Part II |
Leopoldo Rivera-Castaño |
| 9 |
[GO] |
2021―May―21 |
Obstructive sleep apnea is a risk comorbidity for COVID-19 fatality: A review. Part I |
Leopoldo Rivera-Castaño |
| 10 |
[GO] |
2021―May―21 |
Guillain-Barré syndrome and variants associated with SARS-CoV-2 infection in Mexico |
Esther Y. Pérez-Valdez, Juan C. López-Hernández, Raúl N. May-Mas, Maria E. Briseño-Godínez, Javier A. Galnares-Olalde, Jorge de-Saráchaga-Adib, et al. (+4) Elizabeth León-Manríquez, Juan M. Calleja-Castillo, José de J. Flores-Rivera, Edwin S. Vargas-Cañas |
| 11 |
[GO] |
2021―Mar―18 |
SARS-CoV-2 as a future cause of dementia. Is anosmia as “benign” as we think? |
Paola Guraieb-Chahín |
| 12 |
[GO] |
2021―Feb―12 |
Editorial, January 2021: COVID-19 is here. What comes next? |
Ildefonso Rodríguez-Leyva |
| 13 |
[GO] |
2020―Dec―02 |
The time of COVID-19: Clinical approaches and research within 2 months of arriving in Mexico |
Gisela Vázquez-Flores, Marie Catherine Boll |
| 14 |
[GO] |
2020―Oct―21 |
COVID-19 and Guillain-Barré Syndrome: A fortuitous relationship?COVID-19 and Guillain-Barré Syndrome: A fortuitous relationship? |
Hector J. Piñera-Castro |
| 15 |
[GO] |
2020―Aug―05 |
The underrated nervous system involvement by COVID-19 |
Hector R. Martínez, Jose A. Figueroa-Sánchez, Fernando Castilleja-Leal, Michel F. Martínez-Reséndez, Ana S. Ferrigno |
| 16 |
[GO] |
2020―Aug―05 |
Neurological manifestations associated with SARS-CoV-2 - A review |
David A. Aguilar-Andino |
| 17 |
[GO] |
2020―May―14 |
Nervous system and COVID-19 |
Bertha Torres-Oliva, Karina Vélez-Jiménez, Idelfonso Rodríguez-Leyva, Lorena Guerrero-Torres |
